Healthcare Services

Increasing coronary artery disease cases are driving expansion in the coronary artery disease market

April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

“What Is The Forecasted Market Size Trajectory Of The Coronary Artery Disease Market From 2026 To 2030?

The coronary artery disease market has experienced rapid growth in recent years. Its value is projected to rise from $31.88 billion in 2025 to $35.27 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.6%. The expansion observed in the past can be attributed to elements such as the widespread occurrence of cardiovascular disease, sedentary lifestyles, tobacco consumption, insufficient understanding of preventive care, and healthcare models centered around hospitals.

The coronary artery disease market is anticipated to experience substantial growth in the upcoming years, projected to reach $53.97 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.2%. This expansion during the forecast period is primarily driven by factors such as the aging global population, increasing obesity rates, advancements in diagnostic technologies, the growth of preventive cardiology, and improved healthcare access. Significant trends expected during this period include a heightened focus on early disease detection, the rising application of combination drug therapies, the development of lifestyle modification programs, an expansion of minimally invasive treatments, and the integration of cardiac rehabilitation services.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

Which Major Drivers Are Influencing The Expansion Of The Coronary Artery Disease Market?

The increasing incidence of coronary artery disease is projected to drive the expansion of the coronary artery disease market over the forthcoming years. Coronary artery disease (CAD) refers to a medical condition characterized by the constricting or blocking of the coronary arteries, which are responsible for supplying blood to the heart muscle. Cases of coronary artery disease are escalating due to evolving dietary patterns, heightened stress levels, inadequate exercise, obesity, aging, and other contributing factors. Coronary artery disease is managed with pharmaceuticals such as clopidogrel, ticagrelor, warfarin, and heparin, and through procedures like coronary artery bypass grafting, angioplasty, and stenting. For example, in October 2025, data from the Australian Institute of Health and Welfare, an Australia-based government agency, indicated that in 2023, an estimated 2,700 acute coronary events occurred among First Nations people aged 25 and older. When accounting for the population’s age structure, the frequency of these events was 2.8 times higher than what was observed in non-Indigenous people. Therefore, the rise in the prevalence of coronary artery disease is anticipated to boost the coronary artery disease market during the forecast period.

What Are The Key Segment Divisions In The Coronary Artery Disease Market Segment Structure?

The coronary artery disease market covered in this report is segmented –

1) By Treatment: Medication, Surgery, Additional Therapy, Other Treatments

2) By Diagnosis: Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart CT Scan, Other Diagnosis

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

4) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Medication: Antiplatelet Agents, Beta-Blockers, Statins, ACE Inhibitors

2) By Surgery: Coronary Artery Bypass Grafting, Angioplasty And Stenting, Heart Valve Surgery

3) By Additional Therapy: Cardiac Rehabilitation, Lifestyle Modification Programs, Alternative Therapies

4) By Other Treatments: Gene Therapy, Stem Cell Therapy, Innovative Devices

Which Trends Are Shaping The Coronary Artery Disease Market?

Leading firms in the coronary artery disease market are concentrating on creating novel products, like drug-coated balloon catheters, to boost their earnings within the market. These drug-coated balloon catheters represent medical devices utilized in interventional cardiology to address constricted or obstructed blood vessels, specifically for coronary artery disease or peripheral artery disease. As an example, in March 2024, Boston Scientific Corporation, a US-based medical device manufacturer, revealed that the US Food and Drug Administration (FDA) had approved its AGENT Drug-Coated Balloon (DCB), designed for treating coronary in-stent restenosis (ISR) in individuals with coronary artery disease. ISR refers to the blockage or tightening of a stented blood vessel due to plaque or scar tissue formation. The AGENT DCB presents a specialized treatment alternative for the difficult issue of in-stent restenosis (ISR), thereby fulfilling a crucial unmet medical requirement. Its design specifically targets the treatment of ISR and also addresses previously unmanaged small vessel coronary disease. Currently accessible in Europe, certain regions of Asia Pacific, and Latin America, the AGENT DCB delivers a focused remedy for these intricate cardiovascular ailments.

Which Organizations Are Engaged In The Coronary Artery Disease Market?

Major companies operating in the coronary artery disease market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Wockhardt Ltd., Kowa Pharmaceuticals America Inc., Barr Pharmaceuticals Inc., AdvanceCor GmbH, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) e.V.

Get The Full Coronary Artery Disease Market Report:

https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

Which Region Is The Leading Market For The Coronary Artery Disease Market?

North America was the largest region in the coronary artery disease market in 2025. The regions covered in the coronary artery disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Coronary Artery Disease Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

Browse Through More Reports Similar to the Global Coronary Artery Disease Market 2026, By The Business Research Company

Coronary Pressure Market Report 2026

https://www.thebusinessresearchcompany.com/report/coronary-pressure-global-market-report

Acute Coronary Syndrome Market Report 2026

https://www.thebusinessresearchcompany.com/report/acute-coronary-syndrome-global-market-report

Coronary Stents Market Report 2026

https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795